Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acapodene Chemoprevention in High Grade PIN
NCT00028353Phase 2Completed
- Sponsor
- GTx
- Start
- Apr 2001
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of toremifene in Prostate Intraepithelial Neoplasia (PIN) (4 arms), sponsored by GTx. Primary endpoint: Incidence of Prostate Cancer at 12 months. Started Apr 2001; status: completed.
02
Drugs
toremifene
03
Conditions
Prostate Intraepithelial Neoplasia (PIN)
Beyond the preview
Go deeper on NCT00028353.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00028353.